These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli? Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KMG, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM. Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038 [Abstract] [Full Text] [Related]
6. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT. Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR. Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400 [Abstract] [Full Text] [Related]
12. Comparing the role of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer. Ghaedian T, Abdinejad M, Nasrollahi H, Ghaedian M, Firuzyar T. Nucl Med Commun; 2023 Oct 01; 44(10):864-869. PubMed ID: 37464793 [Abstract] [Full Text] [Related]
13. 68Ga-PSMA PET/CT for the evaluation of metastasis in patients with prostate cancer: A systematic review and meta-analysis. Zhou J, Wu R, Wang W, Zhao Y, Liu X. Hell J Nucl Med; 2022 Oct 01; 25(3):297-311. PubMed ID: 36576728 [Abstract] [Full Text] [Related]
14. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Lancet Oncol; 2022 Dec 01; 23(12):1499-1507. PubMed ID: 36343655 [Abstract] [Full Text] [Related]
15. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL, Xue YL, Song HJ, Luo QY. Nucl Med Commun; 2012 Dec 01; 33(12):1232-42. PubMed ID: 23111353 [Abstract] [Full Text] [Related]
16. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, Tamaki N, Schwaiger M, Maurer T, Eiber M. Eur J Nucl Med Mol Imaging; 2016 Nov 01; 43(12):2114-2121. PubMed ID: 27290607 [Abstract] [Full Text] [Related]
20. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? Simsek DH, Sanli Y, Civan C, Engin MN, Isik EG, Ozkan ZG, Kuyumcu S. Ann Nucl Med; 2020 Jul 01; 34(7):476-485. PubMed ID: 32394269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]